Event Information:
Dates
February 26th to 27th, 2025
Location
Zurich, Switzerland
Related Models
TransCure BioServices at the 18th Annual European Life Sciences CEO Forum
We are pleased to announce that our CEO, Sébastien Tabruyn, will be attending the 18th Annual European Life Sciences CEO Forum on February 26-27, 2025, in Zurich, Switzerland.
This premier event brings together biotech executives, investors, and industry leaders to foster innovation, discuss market trends, and explore strategic partnerships in the life sciences sector.
At TransCure BioServices, we specialize in preclinical research using humanized mouse models, providing biotech and pharma companies with cutting-edge in vivo solutions for drug development in oncology, inflammatory diseases, and liver researchoncology, inflammatory diseases, and liver research.
📅 Don’t miss the opportunity to connect with us!
👉 For more details about the event, visit: https://www.sachsforum.com/18elsf-about.html
To book a meeting with Sébastien Tabruyn and discover how our humanized mouse models can accelerate your preclinical research:
Attending in person for TransCure BioServices:
Sebastien Tabruyn, PhD, CEO
Sebastien Tabruyn holds a PhD in Molecular Biology from the University of Liege (Belgium). With over 20 years of experience as a Project Leader in worldwide academic research institutes, including UCSF (California, USA), the Centre for Cancer Biology (Adelaide, Australia), and the University of Maastricht (Netherlands), Sebastien joined TransCure bioServices in 2013 to develop the first immune-oncology humanized mouse models. Before taking on the role of CEO, Sebastien served as the company’s Chief Scientific Officer for six years, where he was instrumental in driving scientific excellence and innovation. Sebastien Tabruyn has published more than 35 peer-reviewed publications, primarily focusing on oncology, inflammation, immunity, and angiogenesis. As CEO, Sebastien commits his leadership and vision to the expansion of TransCure bioServices through the successful delivery of its client needs.